Particle Characterization with Dynamic Image Analysis
White Paper Jun 22, 2015
Higher resolution, lower detection limit, and better reproducibility: that is what Dynamic Image Analysis offers the next generation of size analysis instruments. This white paper outlines how the method works, and shows application examples from typical granulation processes. Pros and cons compared to established methods, like sieving and laser diffraction, are discussed.
Traditionally, particle size distribution analysis of pharmaceutical powders and granules is carried out by sieve analysis, microscopy or with laser diffraction. These methods are established in the pharmacopoeia and used routinely in pharmaceutical laboratories all over the world.
With the introduction of Dynamic Image Analysis (DIA) as an alternative method, it is now possible to measure particle sizes >1 micron of powders, granules, pellets and suspensions as well as particle shape. A number of trials clearly demonstrate the advantages of DIA compared to the established particle sizing methods. In addition to particle size analysis with very high resolution, image analysis provides important information about the particle shape. Many pharmaceutical companies have already recognized the potential of this method, and added this instrumentation to their research and quality control labs, for example for the analysis of multi-particulate dosage forms.
Related White Papers
8 Reasons why it’s Time to Upgrade to Automated ImagingWhite Paper
Why automated image analysis is rapidly replacing manual microscopy for characterizing particle shape and how combining it with Raman spectroscopy adds chemical identification.READ MORE
7 Key Factors When Considering a Benchtop X-ray DiffractometerWhite Paper
In this white paper, our marketing director of the America’s Kathy Macchiarola outlines the important decisions factors that are key requirements and help you select a benchtop system ideal for your situation and your needs.READ MORE
The Use of EDXRF for Pharmaceutical Material Elemental AnalysisWhite Paper
The recent changes to the United States Pharmacopeia (USP) regarding requirements for elemental impurity testing has peaked interest into new ways to perform this testing. Combining these new requirements with the introduction of USP chapter <735> X-ray fluorescence spectrometry1 permits a new alternate method for quantifying elemental impurities in pharmaceutical materials.READ MORE
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018